Brodkin J - Search Results

1

Validation and implementation of a novel high-throughput behavioral phenotyping instrument for mice.

Brodkin J, Frank D, Grippo R, Hausfater M, Gulinello M, Achterholt N, Gutzen C. Brodkin J, et al. J Neurosci Methods. 2014 Mar 15;224:48-57. doi: 10.1016/j.jneumeth.2013.12.010. Epub 2013 Dec 31. J Neurosci Methods. 2014. PMID: 24384067 Free PMC article.

2

Prenatal deletion of the RNA-binding protein HuD disrupts postnatal cortical circuit maturation and behavior.

DeBoer EM, Azevedo R, Vega TA, Brodkin J, Akamatsu W, Okano H, Wagner GC, Rasin MR. DeBoer EM, et al. Among authors: brodkin j. J Neurosci. 2014 Mar 5;34(10):3674-86. doi: 10.1523/JNEUROSCI.3703-13.2014. J Neurosci. 2014. PMID: 24599466 Free PMC article.

3

Reduced stress-induced hyperthermia in mGluR5 knockout mice.

Brodkin J, Bradbury M, Busse C, Warren N, Bristow LJ, Varney MA. Brodkin J, et al. Eur J Neurosci. 2002 Dec;16(11):2241-4. doi: 10.1046/j.1460-9568.2002.02294.x. Eur J Neurosci. 2002. PMID: 12473093

4

A novel apparatus for measuring rat locomotor behavior.

Brodkin J, Nash JF. Brodkin J, et al. J Neurosci Methods. 1995 Apr;57(2):171-6. doi: 10.1016/0165-0270(94)00145-7. J Neurosci Methods. 1995. PMID: 7609580

5

Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone.

Brodkin J, Busse C, Sukoff SJ, Varney MA. Brodkin J, et al. Pharmacol Biochem Behav. 2002 Sep;73(2):359-66. doi: 10.1016/s0091-3057(02)00828-6. Pharmacol Biochem Behav. 2002. PMID: 12117590

6

The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.

Busse CS, Brodkin J, Tattersall D, Anderson JJ, Warren N, Tehrani L, Bristow LJ, Varney MA, Cosford ND. Busse CS, et al. Among authors: brodkin j. Neuropsychopharmacology. 2004 Nov;29(11):1971-9. doi: 10.1038/sj.npp.1300540. Neuropsychopharmacology. 2004. PMID: 15305166

7

3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity.

Cosford ND, Tehrani L, Roppe J, Schweiger E, Smith ND, Anderson J, Bristow L, Brodkin J, Jiang X, McDonald I, Rao S, Washburn M, Varney MA. Cosford ND, et al. Among authors: brodkin j. J Med Chem. 2003 Jan 16;46(2):204-6. doi: 10.1021/jm025570j. J Med Chem. 2003. PMID: 12519057

8

Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity.

Roppe J, Smith ND, Huang D, Tehrani L, Wang B, Anderson J, Brodkin J, Chung J, Jiang X, King C, Munoz B, Varney MA, Prasit P, Cosford ND. Roppe J, et al. Among authors: brodkin j. J Med Chem. 2004 Sep 9;47(19):4645-8. doi: 10.1021/jm049828c. J Med Chem. 2004. PMID: 15341479

9

5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity.

Roppe JR, Wang B, Huang D, Tehrani L, Kamenecka T, Schweiger EJ, Anderson JJ, Brodkin J, Jiang X, Cramer M, Chung J, Reyes-Manalo G, Munoz B, Cosford ND. Roppe JR, et al. Among authors: brodkin j. Bioorg Med Chem Lett. 2004 Aug 2;14(15):3993-6. doi: 10.1016/j.bmcl.2004.05.037. Bioorg Med Chem Lett. 2004. PMID: 15225713

10

Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors.

Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA. Nash JF, et al. Among authors: brodkin jd. Neurosci Lett. 1994 Aug 15;177(1-2):111-5. doi: 10.1016/0304-3940(94)90057-4. Neurosci Lett. 1994. PMID: 7824160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters